Thomas Stinchcombe, MD

I am a professor of medicine in the Duke School of Medicine, division of medical oncology, and a member of Duke Cancer Institute. I specialize in thoracic oncology, and my research focus is clinical trials for non-small-cell and small-cell lung cancer. I serve as the respiratory chair for the Alliance within National Clinical Trials Network (NCTN), the thoracic oncology editor for Journal of Clinical Oncology (JCO), and the chair of the multidisciplinary science committee for the International Association for the Study of Lung Cancer (IASLC).
Financial relationships
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Takeda, Gilead Sciences, Coherus Biosciences Boehringer Ingelheim, Pfizer Abbvie, Janssen OncologyTopic:Lung cancerDate added:07/06/2025Date updated:07/06/2025Relationship end date:07/06/2025
-
Attribution:OtherType of financial relationship:Financial SupportIneligible company:Seagen, Mirati Therapeutics, Nuvalent, Inc. Boehringer IngelheimTopic:Institution (clinical trials)Date added:07/06/2025Date updated:07/06/2025Relationship end date:07/06/2025
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:GSK, Genentech, Merck, SeagenTopic:DMSBDate added:07/06/2025Date updated:07/06/2025Relationship end date:07/06/2025